drugset / Trial / NCT04291729
Evaluation of Ganovo （Danoprevir ） Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection
Phase 4
Completed
11 enrolled
The Ninth Hospital of Nanchang
Ascletis Pharmaceuticals Co., Ltd. · collab
NaSingle-groupOpen-labelTreatment
Summary
Evaluation of the efficacy and safety of Ganovo combined with ritonavir for patients infected with SARS-CoV-2.
Timeline
- Start
- 2020-02-17
- Primary completion
- 2020-03-19
- Completion
- 2020-03-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | danoprevir | Small molecule | 100 mg | Oral |
| Background | Ritonavir | Other / unclassified | 100 mg | — |